Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Wuxi Apptec CO Ltd
(OP:
WUXIF
)
4.230
UNCHANGED
Streaming Delayed Price
Updated: 9:30 AM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,360
Open
4.230
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
4.230
Today's Range
4.230 - 4.230
52wk Range
3.740 - 12.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
August 03, 2024
Shanghai ImmuneOnco Biopharma out-licensed global rites (ex-China) for two of its antibodies to Instil Bio of Dallas, Texas. ImmuneOnco will receive an upfront and near-term payments of $50 million,...
Via
Talk Markets
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal
July 13, 2024
In other news, Sichuan Biokin Pharma has filed for an IPO on the Hong Kong Exchange; more on the Biosecure Act being pushed by US Speaker of the House Johnson.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Performance
YTD
-60.35%
-60.35%
1 Month
N/A
N/A
3 Month
+13.10%
+13.10%
6 Month
-28.32%
-28.32%
1 Year
-66.66%
-66.66%
More News
Read More
Week In Review: Sciwind, Sino Biological And Biocytogen Announce Deals
May 11, 2024
Via
Talk Markets
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
March 30, 2024
Via
Talk Markets
Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities
March 23, 2024
Via
Talk Markets
Week In Review: Under Pressure From US Congress, WuXi AppTec Resigns From BIO
March 16, 2024
Via
Talk Markets
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
March 13, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.